Advocacy

Sokomoto/IAVIIAVI is committed to ensuring that when HIV vaccines become available, they will be accessible and affordable to people in developing countries. The organization typically requires its partners in research and development to agree to a framework for affordability and availability that will ensure global access to future HIV vaccines.

The Scripps Research CenterDevising a vaccine that can elicit effective antibodies against HIV remains one of the greatest challenges of modern science. This is because HIV changes its genetic makeup (mutates) so fast that it continuously evades targeting by the immune response.